Literature DB >> 3125253

Cell surface expression and alloantigenic function of a human class I MHC heavy chain gene (HLA-B7) in transgenic mice.

J W Chamberlain1, J A Nolan, S H Gromkowski, K A Kelley, J M Eisenstadt, K Herrup, C A Janeway, S M Weissman.   

Abstract

We have introduced the gene encoding the heavy chain of the human MHC class I Ag HLA-B7 into transgenic mice. The gene was shown to be expressed at both the RNA and protein level. Cell surface HLA-B7 was detected on whole spleen cells by immunoprecipitation and on purified T cells by flow cytometry (FACS). Normal mice immunized with H-2-syngeneic B7-transgenic spleen cells generated CTL capable of killing transgenic cells and B7-expressing human JY cells. Anti-HLA mAb blocked the killing of JY cells. These results indicate that the human class I Ag HLA-B7 can be expressed at the surface of transgenic spleen cells in the absence of human beta 2-microglobulin, and that a significant fraction exists in a form recognizable by nontransgenic CTL as a major histocompatibility Ag unrestricted by H-2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3125253

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Identification of cis sequences controlling efficient position-independent tissue-specific expression of human major histocompatibility complex class I genes in transgenic mice.

Authors:  J W Chamberlain; H A Vasavada; S Ganguly; S M Weissman
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

2.  Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.

Authors:  Zoltan Antal; Jason C Baker; Carla Smith; Irene Jarchum; Jeffrey Babad; Gayatri Mukherjee; Yang Yang; John Sidney; Alessandro Sette; Pere Santamaria; Teresa P DiLorenzo
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

3.  Mouse cytotoxic T cells can recognize HLA-B27 antigen without H-2 restriction.

Authors:  A Samaan; D Gillet; M Chopin; L Degos; M Pla
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Multiple enhancer-like sequences in the HLA-B7 gene.

Authors:  S Ganguly; H A Vasavada; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  Self-tolerance to HLA focuses the response of immunized HLA-transgenic mice on production of antibody to precise polymorphic HLA alloantigens.

Authors:  G J Hämmerling; J W Chamberlain; O Dill; S Y Yang; B Dupont; R Khan; R Chua; S M Weissman; U Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  Chromosomal mapping of the second human CD8B gene locus.

Authors:  X L Zhang; H H Heng; Y Yang; L C Tsui; J R Parnes; J W Chamberlain
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 7.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

8.  Recognition of HLA-B27 by mouse cytotoxic T-cell clones: a transgenic mouse model.

Authors:  M Reboul; B Frangoulis; A Rocca; L Degos; M Pla
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

9.  Tissue-specific and cell surface expression of human major histocompatibility complex class I heavy (HLA-B7) and light (beta 2-microglobulin) chain genes in transgenic mice.

Authors:  J W Chamberlain; J A Nolan; P J Conrad; H A Vasavada; H H Vasavada; H L Ploegh; S Ganguly; C A Janeway; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  A transcriptional silencer controls the developmental expression of the CD4 gene.

Authors:  G Siu; A L Wurster; D D Duncan; T M Soliman; S M Hedrick
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.